Funded Tech Companies

KAI Pharmaceuticals

KAI Pharmaceuticals, operating out of South San Francisco, was purchased by Amgen.

Company Overview

Contact Information

Company Background Information

Overview

KAI Pharmaceuticals is a biology-based product-driven pharmaceutical company developing a new class of therapeutics targeting cell-signaling enzymes that affect numerous disease pathways. The company is leveraging its leadership position in protein kinase C (PKC), an important and validated family of kinases, to rapidly advance product candidates into human clinical trials.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/10/2012

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Steven James

        

Chief Medical Officer

Gregory Bell

        

VP - Product Management

Susan Wilson

        

VP - R & D

Randolph Johnson

        

Company Investors

• InterWest Partners
• Skyline Ventures
• Aberdare Ventures (Daniel Kisner)
• Investor Growth Capital
• Intersouth Partners
• Delphi Ventures
• Thomas Weisel Venture Partners

Browse more funded tech companies:

Kai Medical | Kai Sensors

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary